Who is sponsoring NCT05905146?

NCT05905146 is sponsored by University Hospital, Rouen.

What drugs are being tested in NCT05905146?

Interventions in NCT05905146: personalized pharmaceutical plan.

What condition does NCT05905146 study?

NCT05905146 studies Acute Pathology of the Locomotor System.

Is NCT05905146 still recruiting?

NCT05905146 is currently recruiting now. Last updated 6 February 2026.

Last reviewed 2026-02-06 · How we verify

NCT05905146: PPPCARE II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.

Recruiting now NA Last updated 6 February 2026

What this trial tests

NA trial testing personalized pharmaceutical plan in Acute Pathology of the Locomotor System in 200 participants. Currently enrolling.

Timeline

18 January 2024

Primary endpoint
18 July 2028

18 July 2028

Quick facts

Lead sponsor	University Hospital, Rouen
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	200
Start date	18 January 2024
Primary completion	18 July 2028
Estimated completion	18 July 2028
Sites	3 locations across France

Drugs / interventions tested

personalized pharmaceutical plan

Conditions studied

Acute Pathology of the Locomotor System — all drugs for Acute Pathology of the Locomotor System →

Sponsor

University Hospital, Rouen

Who can join

18 and older, any sex, with Acute Pathology of the Locomotor System. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Rouen trials

Trials by the same sponsor.

NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05905146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
Last refreshed: 6 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing